content_image/1058627.jpg content_image/1058628.jpg content_image/1058629.jpg
<img src='content_image/1058627.jpg'>

(a) Included amounts for Power, Renewable Energy, Aviation and Healthcare, for which our measure of segment profit excludes interest and other financial charges and income taxes. 

<img src='content_image/1058628.jpg'>

(a) Additions to property, plant and equipment include amounts relating to principal businesses purchased. 

(b) Included amortization expense related to intangible assets. 

(c) Included Capital deferred income taxes that are presented as assets for purposes of our balance sheet presentation. 

(d) Included GE Industrial deferred income taxes that are presented as assets for purposes of our balance sheet presentation. 

We classify certain assets that cannot meaningfully be associated with specific geographic areas as “Other Global” for this purpose. 

<img src='content_image/1058629.jpg'>

The decrease in continuing assets in 2020 was primarily driven by lower volume and the impact of COVID-19, higher net repayment of borrowings, and funding of the GE Pension Plan. The sale of our BioPharma business caused a decrease in assets in different regions, but was more than offset by the proceeds from the sale in the U.S. 

Property, plant and equipment – net associated with operations based in the United States were $13,010 million and $13,447 million at December 31, 2020 and 2019, respectively. Property, plant and equipment – net associated with operations based outside the United States were $31,651 million and $32,432 million at December 31, 2020 and 2019, respectively. 

